INTRODUCTION: Intensity-modulated radiation therapy (IMRT) is an advanced treatment delivery technique that can improve the therapeutic dose ratio. Its use in the treatment of inoperable non-small cell lung cancer (NSCLC) has not been well studied. This report reviews our experience with IMRT for patients with inoperable NSCLC. METHODS AND MATERIALS: We performed a retrospective review of 55 patients with stage I-IIIB inoperable NSCLC treated with IMRT at our institution between 2001 and 2005. The study endpoints were toxicity, local control, and overall survival. RESULTS: With a median follow-up of 26 months, the 2-year local control and overall survival rates for stage I/II patients were 50% and 55%, respectively. For the stage III patients, 2-year local control and overall survival rates were 58% and 58%, respectively, with a median survival time of 25 months. Six patients (11%) experienced grade 3 acute pulmonary toxicity. There were no acute treatment-related deaths. Two patients (4%) had grade 3 or worse late treatment-related pulmonary toxicity. CONCLUSIONS: IMRT treatment resulted in promising outcomes for inoperable NSCLC patients.
INTRODUCTION: Intensity-modulated radiation therapy (IMRT) is an advanced treatment delivery technique that can improve the therapeutic dose ratio. Its use in the treatment of inoperable non-small cell lung cancer (NSCLC) has not been well studied. This report reviews our experience with IMRT for patients with inoperable NSCLC. METHODS AND MATERIALS: We performed a retrospective review of 55 patients with stage I-IIIB inoperable NSCLC treated with IMRT at our institution between 2001 and 2005. The study endpoints were toxicity, local control, and overall survival. RESULTS: With a median follow-up of 26 months, the 2-year local control and overall survival rates for stage I/II patients were 50% and 55%, respectively. For the stage III patients, 2-year local control and overall survival rates were 58% and 58%, respectively, with a median survival time of 25 months. Six patients (11%) experienced grade 3 acute pulmonary toxicity. There were no acute treatment-related deaths. Two patients (4%) had grade 3 or worse late treatment-related pulmonary toxicity. CONCLUSIONS: IMRT treatment resulted in promising outcomes for inoperable NSCLCpatients.
Authors: J A Hayman; M K Martel; R K Ten Haken; D P Normolle; R F Todd; J F Littles; M A Sullivan; P W Possert; A T Turrisi; A S Lichter Journal: J Clin Oncol Date: 2001-01-01 Impact factor: 44.544
Authors: Ellen D Yorke; Lu Wang; Kenneth E Rosenzweig; Dennis Mah; Jean-Baptiste Paoli; Chen-Shou Chui Journal: Int J Radiat Oncol Biol Phys Date: 2002-07-15 Impact factor: 7.038
Authors: Cesar Della Biancia; Ellen Yorke; Chen-Shou Chui; Philippe Giraud; Kenneth Rosenzweig; Howard Amols; Clifton Ling; Gig S Mageras Journal: Radiother Oncol Date: 2005-05 Impact factor: 6.280
Authors: Chandra P Belani; Hak Choy; Phil Bonomi; Charles Scott; Patrick Travis; John Haluschak; Walter J Curran Journal: J Clin Oncol Date: 2005-08-08 Impact factor: 44.544
Authors: Kenneth E Rosenzweig; Jana L Fox; Ellen Yorke; Howard Amols; Andrew Jackson; Valerie Rusch; Mark G Kris; Clif C Ling; Steven A Leibel Journal: Cancer Date: 2005-05-15 Impact factor: 6.860
Authors: Jeffrey Bradley; Mary V Graham; Kathryn Winter; James A Purdy; Ritsuko Komaki; Wilson H Roa; Janice K Ryu; Walter Bosch; Bahman Emami Journal: Int J Radiat Oncol Biol Phys Date: 2005-02-01 Impact factor: 7.038
Authors: K E Rosenzweig; B Mychalczak; Z Fuks; J Hanley; C Burman; C C Ling; J Armstrong; R Ginsberg; M G Kris; A Raben; S Leibel Journal: Cancer J Date: 2000 Mar-Apr Impact factor: 3.360
Authors: Lawrence B Marks; Soren M Bentzen; Joseph O Deasy; Feng-Ming Spring Kong; Jeffrey D Bradley; Ivan S Vogelius; Issam El Naqa; Jessica L Hubbs; Joos V Lebesque; Robert D Timmerman; Mary K Martel; Andrew Jackson Journal: Int J Radiat Oncol Biol Phys Date: 2010-03-01 Impact factor: 7.038
Authors: Shervin M Shirvani; Jing Jiang; Daniel R Gomez; Joe Y Chang; Thomas A Buchholz; Benjamin D Smith Journal: Lung Cancer Date: 2013-08-21 Impact factor: 5.705
Authors: Yevgeniy Vinogradskiy; Chad G Rusthoven; Leah Schubert; Bernard Jones; Austin Faught; Richard Castillo; Edward Castillo; Laurie E Gaspar; Jennifer Kwak; Timothy Waxweiler; Michele Dougherty; Dexiang Gao; Craig Stevens; Moyed Miften; Brian Kavanagh; Thomas Guerrero; Inga Grills Journal: Int J Radiat Oncol Biol Phys Date: 2018-10-18 Impact factor: 7.038
Authors: J B Adkison; D Khuntia; S M Bentzen; G M Cannon; W A Tome; H Jaradat; W Walker; A M Traynor; T Weigel; M P Mehta Journal: Technol Cancer Res Treat Date: 2008-12